INR 2.59
(-4.07%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 43.1 Million | 14.67 Million | -7.77 Million | 31.69 Million | 58.07 Million | -3.17 Million |
Net Income | -41.49 Million | 20.49 Million | 770 Thousand | -35.04 Million | -7.83 Million | -13.08 Million |
Depreciation & Amortization | 22.54 Million | 7.88 Million | 9.97 Million | 19.15 Million | 1.66 Million | 6.66 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 8.44 Million | -34.91 Million | -18.51 Million | 47.58 Million | 58.2 Million | 3.25 Million |
Other non-cash items | 85.74 Million | 21.2 Million | 23.12 Million | -1000.00 | 6.04 Million | 3.25 Million |
Investing Cash Flow | -35.93 Million | 845 Thousand | 1.52 Million | 90.75 Million | 42.28 Million | - |
Investments in PPE | -34.58 Million | -447 Thousand | -458 Thousand | - | -20 Thousand | - |
Acquisitions | - | - | - | - | 42.3 Million | - |
Investment purchases | -7.37 Million | - | -21 Thousand | -3.11 Million | - | - |
Sales/Maturities of investments | - | 2000.00 | - | 11 Million | - | - |
Other Investing Activities | -1.35 Million | 1.29 Million | 2 Million | 82.87 Million | 42.3 Million | - |
Financing Cash Flow | -19.91 Million | 98 Thousand | 5.59 Million | -123.78 Million | -100.58 Million | 3.43 Million |
Debt repayment | -17.6 Million | -18.03 Million | -11.29 Million | -137.38 Million | -13.18 Million | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -37.51 Million | 18.13 Million | 16.89 Million | 13.59 Million | -87.4 Million | 3.43 Million |
Accounts receivables | 9.14 Million | -5.92 Million | -5.49 Million | -1.02 Million | - | - |
Accounts payables | 3.93 Million | 885 Thousand | -2.25 Million | 1.02 Million | -135 Thousand | - |
Inventory | -126 Thousand | 732 Thousand | -440 Thousand | 5.06 Million | 56.45 Million | - |
Other working capital | -4.51 Million | -30.61 Million | -10.32 Million | 42.51 Million | 1.88 Million | - |
Cash at beginning of period | 19.8 Million | 4.19 Million | 4.85 Million | 6.18 Million | 346 Thousand | 87 Thousand |
Cash at end of period | 16.67 Million | 19.81 Million | 4.19 Million | 4.85 Million | 116 Thousand | 346 Thousand |
Capital Expenditure | -34.58 Million | -447 Thousand | -458 Thousand | - | -20 Thousand | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -3.13 Million | 15.61 Million | -658 Thousand | -1.33 Million | -230 Thousand | 259 Thousand |
Free Cash Flow | 8.52 Million | 14.22 Million | -8.23 Million | 31.69 Million | 58.05 Million | -3.17 Million |
Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -16.75 Million | -41.49 Million | -23.92 Million | -4.74 Million | -6.09 Million | -6.72 Million |
Depreciation & Amortization | - | 22.54 Million | - | 5.6 Million | 5.12 Million | 5.67 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | 8.44 Million | - | - | - | - |
Other non-cash items | 16.75 Million | 85.74 Million | 23.92 Million | 4.74 Million | 6.09 Million | 6.72 Million |
Investing Cash Flow | - | -35.93 Million | - | - | - | - |
Investments in PPE | - | -34.58 Million | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | -7.37 Million | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | -1.35 Million | - | - | - | - |
Financing Cash Flow | - | -19.91 Million | - | - | - | - |
Debt repayment | - | -17.6 Million | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | 9.14 Million | - | - | - | - |
Accounts payables | - | 3.93 Million | - | - | - | - |
Inventory | - | -126 Thousand | - | - | - | - |
Other working capital | - | -4.51 Million | - | - | - | - |
Cash at beginning of period | - | 19.8 Million | - | 12.49 Million | 18.59 Million | 19.8 Million |
Cash at end of period | - | 16.67 Million | - | 23.71 Million | 12.49 Million | -6.72 Million |
Capital Expenditure | - | -34.58 Million | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | -3.13 Million | - | 11.21 Million | -6.09 Million | -26.52 Million |
Free Cash Flow | - | 8.52 Million | - | 11.21 Million | -6.09 Million | -6.72 Million |
AIXN
FINOPB
SON
POLYMED
WYNMF
2613